"Insulin Infusion Systems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.
| Descriptor ID |
D007332
|
| MeSH Number(s) |
E02.319.300.508 E07.505.508 E07.858.082.505.508
|
| Concept/Terms |
Insulin Infusion Systems- Insulin Infusion Systems
- Infusion System, Insulin
- Infusion Systems, Insulin
- Insulin Infusion System
- System, Insulin Infusion
- Systems, Insulin Infusion
Implantable Programmable Insulin Pump- Implantable Programmable Insulin Pump
- Programmable Implantable Insulin Pump
- Pump, Programmable Implantable Insulin
- Insulin Pump, Programmable Implantable
beta Cell, Artificial- beta Cell, Artificial
- Artificial beta Cell
- Artificial beta Cells
- Cell, Artificial beta
- Cells, Artificial beta
- beta Cells, Artificial
|
Below are MeSH descriptors whose meaning is more general than "Insulin Infusion Systems".
Below are MeSH descriptors whose meaning is more specific than "Insulin Infusion Systems".
This graph shows the total number of publications written about "Insulin Infusion Systems" by people in this website by year, and whether "Insulin Infusion Systems" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 4 | 0 | 4 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Infusion Systems" by people in Profiles.
-
Late Afternoon Vigorous Exercise Increases Postmeal but Not Overnight Hypoglycemia in Adults with Type 1 Diabetes Managed with Automated Insulin Delivery. Diabetes Technol Ther. 2022 Dec; 24(12):873-880.
-
Upload and Review of Insulin Pump and Glucose Sensor Data by Adults with Type 1 Diabetes: A Clinic Audit. Diabetes Technol Ther. 2022 07; 24(7):531-534.
-
A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes. Diabetes Care. 2022 01 01; 45(1):194-203.
-
Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provision. Diabetes Res Clin Pract. 2021 Sep; 179:109000.
-
Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections. Diabetes Technol Ther. 2021 06; 23(6):460-466.
-
A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention. Endocr Pract. 2021 Jun; 27(6):545-551.
-
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial. Diabetes Care. 2020 12; 43(12):3024-3033.
-
HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment. BMJ Open. 2019 12 29; 9(12):e033059.
-
Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study. Diabetes Care. 2020 02; 43(2):480-483.
-
Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study. Diabetes Technol Ther. 2019 09; 21(9):499-506.